tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nathan Rich, 30 are a SELL (22.73%), 52 are a BUY (39.39%), 50 are a HOLD (37.88%).
Analyst Nathan Rich, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 76.85% that have a potential upside of 23.65% achieved within 276 days.
Nathan Rich’s has documented 258 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HUM, Humana at 17-Feb-2026.
Analyst best performing recommendations are on OSCR (OSCAR HEALTH).
The best stock recommendation documented was for OSCR (OSCAR HEALTH) at 8/10/2023. The price target of $7.5 was fulfilled within 1 day with a profit of $0.18 (2.46%) receiving and performance score of 24.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Sep-2020
$22
$1.01 (4.81%)
3 years 9 months 9 days ago
(13-Jun-2022)
3/4 (75%)
$1.33 (6.43%)
299
Buy Since 17-Feb-2021
$21
$0.01 (0.05%)
$26
3 years 9 months 24 days ago
(26-May-2022)
0/4 (0%)
$0.3 (1.45%)
Hold
$21
$0.01 (0.05%)
$19
3 years 9 months 27 days ago
(23-May-2022)
4/5 (80%)
$-1.91 (-8.38%)
397
Hold Since 23-May-2022
3 years 9 months 27 days ago
(23-May-2022)
1/3 (33.33%)
$7.54 (38.75%)
337
Buy Since 12-Aug-2020
$21
$0.01 (0.05%)
3 years 9 months 27 days ago
(23-May-2022)
1/2 (50%)
$1.3 (6.60%)
54
Which stock is Nathan Rich is most bullish on?
What Year was the first public recommendation made by Nathan Rich?
